TENAX THERAPEUTICS, INC. Common Stock, Value, Issued
TENAX THERAPEUTICS, INC. (TENX) had Common Stock, Value, Issued of $3.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-07-31
- 2026-06-30: Common Stock, Value, Issued $3.00K.
- 2026-03-31: Common Stock, Value, Issued $2.00K.
- 2025-12-31: Common Stock, Value, Issued $1.00K.
- 2025-09-30: Common Stock, Value, Issued $1.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.00K 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | |
| 2024-09-30 | $341.00 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $196.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-25 | $30.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $2.39K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.39K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.18K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.00 10-K · filed 2024-03-28 | $4.58K 10-K · filed 2023-03-31 |
| 2022-09-30 | $3.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.52K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.52K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.52K 10-K · filed 2023-03-31 | $0.00 10-K · filed 2022-03-29 |
| 2021-09-30 | $2.52K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.52K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.50K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 | $1.26K 10-K · filed 2021-03-31 |
| 2020-09-30 | $1.26K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.01K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $801.00 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $674.00 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $674.00 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $667.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $615.00 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $379.00 10-K · filed 2020-03-30 | |
| 2018-09-30 | $147.00 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $145.00 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $145.00 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $141.00 10-K · filed 2019-04-01 | |
| 2017-09-30 | $2.82K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.82K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.82K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.81K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $2.81K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.81K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.81K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.81K 10-K · filed 2017-03-16 | |
| 2015-10-31 | $2.81K 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $2.81K 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $2.81K 10-KT · filed 2016-03-14 | |
| 2015-01-31 | $2.81K 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $2.81K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $2.81K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $2.79K 10-KT · filed 2016-03-14 | |
| 2014-01-31 | $1.37K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $682.00 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $306.00 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $193.00 10-K · filed 2014-07-29 | |
| 2013-01-31 | $3.37K 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $3.29K 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $3.11K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $2.94K 10-K · filed 2013-06-26 | |
| 2012-01-31 | $2.82K 10-Q · filed 2012-03-15 | |
| 2011-10-31 | $2.39K 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $2.34K 10-Q · filed 2011-09-19 | |
| 2011-04-30 | $2.34K 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |